The American Journal of Medicine
Volume 122, Issue 3 , Pages 248-256.e5 , March 2009

Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis

  • Henry Buchwald, MD, PhD

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis
    • Corresponding Author InformationRequests for reprints should be addressed to Henry Buchwald, MD, PhD, University of Minnesota, 420 Delaware Street SE, MMC 290, Minneapolis, MN 55455
    • ,
  • Rhonda Estok, RN, BSN

      Affiliations

    • United BioSource Corporation, Medford, Mass
    • ,
  • Kyle Fahrbach, PhD

      Affiliations

    • United BioSource Corporation, Medford, Mass
    • ,
  • Deirdre Banel, BA

      Affiliations

    • United BioSource Corporation, Medford, Mass
    • ,
  • Michael D. Jensen, MD

      Affiliations

    • Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Walter J. Pories, MD

      Affiliations

    • Department of Surgery, East Carolina University School of Medicine, Greenville, NC
    • ,
  • John P. Bantle, MD

      Affiliations

    • Department of Medicine, University of Minnesota, Minneapolis
    • ,
  • Isabella Sledge, MD, MPH

      Affiliations

    • United BioSource Corporation, Medford, Mass

References 

  1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737
  2. Ball C, Sackett D, Phillips B, et al. CEBM website Levels of Evidence and Grades of Recommendation (Centre for Evidence-Based Medicine, October 2006). http://www.cebm.net/levels_of_evidence.aspAccessed January 2, 2007
  3. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  4. Hedges L, Olkin I. Random effects models for effect sizes. In:  Hedges L,  Olkin I editor. Statistical Methods for Metaanalysis. 42:Orlando, FL: Academic Press; 1985;p. 191–200
  5. DerSimonian R, Laird N. Metaanalysis in clinical trials. Control Clin Trials. 1986;7:177–188
  6. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–266
  7. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  8. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23:1278–1283
  9. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–950
  10. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263–1268
  11. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Diabetes Care. 2004;27:1047–1053
  12. Hossain P, Kawar B, Nahas ME. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 2007;356:213–215
  13. The World Health Report 2006 (Working Together for Health). Geneva, Switzerland: Geneva World Health Organization; 2006;
  14. Worldwatch Institute. Chronic hunger and obesity epidemics eroding global progress. http://www.worldwatch.org/node/1672Accessed January 2, 2007
  15. World Health Organization. The global challenge of obesity, 2002. http://www.who.int/dietphysicalactivity/en/Accessed January 2, 2007
  16. Flegal KM, Carol MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes. 1998;22:39–47
  17. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79
  18. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200
  19. North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication #00-4084, Oct 2000.
  20. NHANES III Public Use Data File. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Laboratory Data File (CD-ROM). Public Use Data File Documentation Number 76200. Hyattsville, MD: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service (NTIS), Springfield, VA.
  21. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–797
  22. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677–685
  23. Burstein R, Epstein Y, Charuzi I, et al. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes Relat Metab Disord. 1995;19:558–561
  24. Abbasi F, Brown BW, Lamendola C, et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 2002;40:937–943
  25. National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–961
  26. CDC/NHANES. Overweight and obesity: Obesity trends: U.S. Obesity Trends 1985-2005. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htmAccessed June 18, 2007
  27. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? (An operation proves to be the most effective therapy for adult-onset diabetes mellitus). Ann Surg. 1995;222:339–352
  28. MacDonald KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213–220
  29. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on Type 2 diabetes mellitus. Ann Surg. 2003;238:467–484
  30. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–423
  31. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–551
  32. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527–531
  33. Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?. Ann Surg. 1998;227:637–643
  34. Gannon MC, Nuttall FQ, Lane JT, et al. Effect of 24 hours of starvation on plasma glucose and insulin concentrations in subjects with untreated non-insulin-dependent diabetes mellitus. Metab Clin Exp. 1996;45:492–497
  35. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–749
  36. Arguelles-Sarmiento J, Barnal-Velasquez H, Andujo-Vasquez L, Pories WJ. Control of Type 2 diabetes mellitus in non-obese patients with stomach sparing duodeno-jejunal exclusion (SSDJE): report of the first ten cases. Surg Obes Related Dis. 2009;(in press)
  37. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–635
  38. Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality. JAMA. 2004;292:847–851

 Funding: This work was supported by Ethicon Endo-Surgery, Inc, a Johnson & Johnson Company, Cincinnati, Ohio.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(08)01064-4

doi: 10.1016/j.amjmed.2008.09.041

The American Journal of Medicine
Volume 122, Issue 3 , Pages 248-256.e5 , March 2009

Article Tools

* Image Usage & Resolution